Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04349033 · ClinicalTrials.gov registry record · NA
Virtual Human Technology for Patients With Chronic Pain
A NA study, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT04349033: Completed NA study, sponsored by Wayne State University.
NCT04349033 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04349033, a NA study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The experimental study compares three virtual human interviews of patients with chronic musculoskeletal pain: Emotional disclosure and brain, emotional disclosure only, basic information control. Effects on attitudes and clinical outcomes at 1-month follow-up are assessed.
Primary Outcome
Brief Pain Inventory (average of the 4 pain intensity rating items: highest, lowest, average, now). Range: 0.0 to 10.0 (higher = more severe pain)
Interventions
- BEHAVIORAL Emotional Disclosure and Brain Education
- BEHAVIORAL Emotional Disclosure Only
- BEHAVIORAL Pain Information Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2021-08-01 |
| Phase | NA |
What the finished NCT04349033 record still lists
NCT04349033 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Emotional Disclosure and Brain Education is the first listed.
NCT04349033 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04349033 about?
NCT04349033 is a clinical study titled "Virtual Human Technology for Patients With Chronic Pain". The experimental study compares three virtual human interviews of patients with chronic musculoskeletal pain: Emotional disclosure and brain, emotional disclosure only, basic information control. Effects on attitudes and clinical outcomes at 1-month follow-up are assessed.
What is the current status of trial NCT04349033?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2021-02-10. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT04349033?
The interventions under investigation include: Emotional Disclosure and Brain Education (BEHAVIORAL), Emotional Disclosure Only (BEHAVIORAL), Pain Information Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04349033?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04349033's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI